Oncology dose optimization paradigms: knowledge gained and extrapolated from approved oncology therapeutics
Authors (first, second and last of 4)
Cancer Chemotherapy and Pharmacology addresses a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels. The primary focus of this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.
The journal publishes results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy. Cancer Chemotherapy and Pharmacology is essential reading for pharmacologists and oncologists.
- Addresses a wide range of pharmacologic and oncologic concerns
- Focuses on new anticancer agents, screening, toxicology, drug administration modalities and clinical trials
- Offers results in related fields: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy
- 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Co-Editors-in-Chief
-
- Etienne Chatelut
- Co-Editor-in-Chief
-
- Jan Hendrik Beumer
- Publishing model
- Hybrid (Transformative Journal). How to publish with us, including Open Access
Journal metrics
- 3.288 (2021)
- Impact factor
- 3.581 (2021)
- Five year impact factor
- 8 days
- Submission to first decision (Median)
- 582,393 (2021)
- Downloads
Latest issue
Latest articles
-
-
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia
Authors (first, second and last of 10)
-
A bavachinin analog, D36, induces cell death by targeting both autophagy and apoptosis pathway in acute myeloid leukemia cells
Authors (first, second and last of 4)
-
Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity
Authors (first, second and last of 7)
-
An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next
Authors (first, second and last of 7)
Journal updates
-
Learn more about Springer Nature’s oncology titles
Discover the range of academic oncology titles at Springer Nature here.
-
Announcing new Co-Editor-in-Chief: Dr. Jan Beumer
The journal is pleased to announce Dr. Jan Beumer has been named the new Co-Editor-in-Chief of Cancer Chemotherapy and Pharmacology, effective January 1, 2020.
About this journal
- Electronic ISSN
- 1432-0843
- Print ISSN
- 0344-5704
- Abstracted and indexed in
-
- AGRICOLA
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO CINAHL
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- EMCare
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- Pathway Studio
- Portico
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information
